Table 5.

Comparative analysis of BCL-6 and IgvH mutations in selected B-cell malignancies

HistologyBCL-6M/IgVM5-150BCL-6G/IgVM5-150BCL-6G/IgVG5-150Mean Frequency of Mutation (range)
BCL-6IgVH
Follicular lymphoma (n = 15) 9/15 (60.0%)  6/15 (40.0%)  0/15 0.83 × 10−2 bp  9.8 × 10−2bp  
    (0.27-1.1)   (5.4-18.2)  
MALT lymphoma (n = 15)  5/15 (33.3%)  10/15 (66.7%)  0/15 0.75 × 10−2 bp  8.1 × 10−2bp  
    (0.27-1.9)   (3.2-15.5)  
Hairy cell leukemia (n = 8)  2/8 (25.0%)  4/8 (50.0%) 2/8 (25.0%)  0.27 × 10−2 bp 6.9 × 10−2 bp  
    (0.13-0.40) (3.3-10.8) 
HistologyBCL-6M/IgVM5-150BCL-6G/IgVM5-150BCL-6G/IgVG5-150Mean Frequency of Mutation (range)
BCL-6IgVH
Follicular lymphoma (n = 15) 9/15 (60.0%)  6/15 (40.0%)  0/15 0.83 × 10−2 bp  9.8 × 10−2bp  
    (0.27-1.1)   (5.4-18.2)  
MALT lymphoma (n = 15)  5/15 (33.3%)  10/15 (66.7%)  0/15 0.75 × 10−2 bp  8.1 × 10−2bp  
    (0.27-1.9)   (3.2-15.5)  
Hairy cell leukemia (n = 8)  2/8 (25.0%)  4/8 (50.0%) 2/8 (25.0%)  0.27 × 10−2 bp 6.9 × 10−2 bp  
    (0.13-0.40) (3.3-10.8) 
F5-150

BCL-6M/IgVM, cases harboring mutated BCL-6 and IgVH genes;BCL-6G/IgVM, cases harboring germlineBCL-6 genes and mutated IgVH genes;BCL-6G/IgVG, cases harboring germlineBCL-6 and IgVH genes. For each category, the number of positive/tested cases is indicated.

Close Modal

or Create an Account

Close Modal
Close Modal